|
The Trump administration on Thursday rolled out a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims to deliver lower prices for their popular GLP-1 drugs to certain Medicare and Medicaid beneficiaries and to users of TrumpRx.gov, the administration's new direct-to-consumer website.
|
|
The president's agreement with drug companies involves a range of prices, depending on dose, product and how you're paying.
|
|
Lilly, Novo to Lower Obesity Drug Prices in Trump Deal Bloomberg.comCertain obesity drugs will cost as little as $149 and Medicare will start covering them under White House deals CNNTrump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage CNBCTrump strikes deal to lower cost of Wegovy, Zepbound weight loss drugs
|
RELATED ARTICLES | | |
|
